Elavil and Eye discharge - a phase IV clinical study of FDA data

Summary:

Eye discharge is reported as a side effect among people who take Elavil (amitriptyline hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Celebrex, and have High blood pressure.

The phase IV clinical study analyzes which people have Eye discharge when taking Elavil. It is created by eHealthMe based on reports of 19,133 people who have side effects when taking Elavil from the FDA, and is updated regularly.

What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.

What is Eye discharge?

Eye discharge is found to be associated with 690 drugs and 802 conditions by eHealthMe. Check the latest studies of Eye discharge.

On Jul, 11, 2026

19,133 people reported to have side effects when taking Elavil.
Among them, 22 people (0.11%) have Eye discharge.

Among these 22 people:

How long have people been on Elavil when they have Eye discharge? *

What is the gender of people who have Eye discharge when taking Elavil? *

female: 50 %
male: 50 %

What is the age of people who have Eye discharge when taking Elavil? *

What are other drugs people take besides Elavil? *

What are other side effects people have besides Eye discharge? *

Fatigue (feeling of tiredness): 19 people, 86.36%
Rhinorrhea (watery mucus discharge from the nose): 18 people, 81.82%
Nasopharyngitis (inflammation of the nasopharynx): 18 people, 81.82%
Eye Infection: 18 people, 81.82%
Diarrhea: 18 people, 81.82%
Urination - Painful: 18 people, 81.82%
Injection Site Pain: 17 people, 77.27%
Gait Disturbance: 12 people, 54.55%
Oropharyngeal Pain: 12 people, 54.55%
Sneezing: 11 people, 50.00%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 54.55%
Pain: 11 people, 50.00%
High Blood Cholesterol: 11 people, 50.00%
Ankylosing Spondylitis (type of arthritis affecting the spine): 11 people, 50.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 31.82%
Visual Impairment: 2 people, 9.09%
Sleep Disorder: 2 people, 9.09%
Retinal Degeneration (death of the cells of the retina): 2 people, 9.09%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 9.09%
Intraocular Pressure Increased: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Elavil and have Eye discharge?

- Check whether Eye discharge is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elavil:

Elavil (20,724 reports)

Eye discharge treatments and more:

Eye discharge (10,525 reports)

Browse all side effects of Elavil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye discharge:

Eye discharge (690 drugs)

Browse all the conditions that are associated with Eye discharge:

Eye discharge (802 conditions)

Related publications that referenced our studies

Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride (the active ingredients of Elavil) and Elavil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.